Grail (GRAL) Cash from Investing Activities (2023 - 2026)
Grail's (GRAL) quarterly Cash from Investing Activities came in at -$46.6 million in Q2 2026, down 166.19% on a YoY basis from $70.4 million in Q2 2025, and up 50.15% quarter-over-quarter from -$93.4 million in Q1 2026.
Analysis
Grail (GRAL) Cash from Investing Activities (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Cash from Investing Activities for 4 consecutive years, with -$46.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Investing Activities fell 166.19% year-over-year to -$46.6 million; the trailing twelve-month figure through Jun 2026 stood at -$310.0 million (up 32.91% YoY), and the FY2025 full-year result was -$85.0 million, up 84.56% from the prior year.
- Cash from Investing Activities grew to -$46.6 million in Q2 2026 per GRAL's latest filing, from -$93.4 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $70.4 million in Q2 2025 and bottomed at -$546.1 million in Q4 2024.
- Historically, Cash from Investing Activities has averaged -$65.3 million across 4 years, with a median of -$2.8 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities tumbled 13920.69% in 2024, then soared 6966.43% in 2025.
- Over 4 years, Cash from Investing Activities stood at -$3.9 million in 2023, then sank by 13920.69% to -$546.1 million in 2024, then soared by 56.66% to -$236.7 million in 2025, then soared by 80.32% to -$46.6 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$46.6 million, -$93.4 million, and -$236.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | -63.43 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | -134.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | -366.20 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 101.47 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | -11.09 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | -122.19 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | -43.30 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | -4.05 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -43.48 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | -46.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -46.58 Mn |
| Mar 31, 2026 | -93.44 Mn |
| Dec 31, 2025 | -236.70 Mn |
| Sep 30, 2025 | 66.67 Mn |
| Jun 30, 2025 | 70.37 Mn |
| Mar 31, 2025 | 14.61 Mn |
| Dec 31, 2024 | -546.11 Mn |
| Sep 30, 2024 | -971,000.00 |
| Jun 30, 2024 | -1.39 Mn |
| Mar 31, 2024 | -2.55 Mn |
| Dec 31, 2023 | -3.90 Mn |
| Oct 1, 2023 | -3.07 Mn |